Lymphoma Trial, Recruiting NCT07147621 Sponsor: University Hospital, Angers Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07147621
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the patient group:

  • Adults diagnosed with acute myeloid leukemia, Hodgkin's lymphoma, or non-Hodgkin's lymphoma
  • People who are receiving a set, fixed-length course of first-line chemotherapy (meaning chemotherapy given as the first treatment for their condition)
  • People who are covered by a social security scheme
  • People who have signed a consent form agreeing to take part

For the comparison (control) group — a close relative or friend of a patient in the trial:

  • Adults who are a relative or close contact of a patient participant (such as a spouse, sibling, or friend)
  • People whose age is within 5 years of the patient they are paired with
  • People who have a similar level of education to the patient they are paired with
  • People who are covered by a social security scheme
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

For the patient group:

  • People who have no suitable relative or close contact available to participate in the control group
  • People with known or suspected thinking or memory difficulties that existed before chemotherapy
  • People with a history of severe neurological or psychiatric conditions (for example, severe depression)
  • People who have previously received chemotherapy
  • People who have previously had radiotherapy to the brain
  • People currently taking medications that are known to affect thinking or memory
  • People who are unable to read
  • People who do not speak French
  • People who are in custody or subject to a judicial or administrative restriction on their liberty
  • People receiving forced psychiatric care
  • People under a legal protection order (confirm with trial site)
  • People who are unable to give their own consent
  • Women who are pregnant or breastfeeding

For the comparison (control) group:

  • People with known or suspected thinking or memory difficulties
  • People with a history of severe neurological or psychiatric conditions (for example, severe depression)
  • People who have previously received chemotherapy
  • People who have previously had radiotherapy to the brain
  • People currently taking medications that are known to affect thinking or memory
  • People who are unable to read
  • People who do not speak French
  • People who are in custody or subject to a judicial or administrative restriction on their liberty
  • People receiving forced psychiatric care
  • People under a legal protection order (confirm with trial site)
  • People who are unable to give their own consent
  • Women who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2 41 35 44 82

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Angers
Registry
ClinicalTrials.gov
Start date
26 February 2026
Est. completion
1 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Changes in cognitive complaints measured by the Functional Assessment of Cancer Therapy - Cognitive function (FACT-Cog) questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov